With a market cap of has a large market cap size. Amgen Inc. (NASDAQ: AMGN) has been on the stock market since its IPO date on the 9/7/1984. Amgen Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Amgen Inc., is 2851.14, and so far today it has a volume of 1671745. Performance year to date since the 9/7/1984 is 7.41%.
To help you determine whether Amgen Inc. is undervalued the following values will help you decide. P/E is 18.2 and forward P/E is 13.88. PEG perhaps more useful shows that Amgen Inc. has a value for PEG of 2.14. P/S ratio is 5.83 and the P/B ratio is 4.28. The P/Cash and P/Free cash flow is *TBA and *TBA respectively.
At the current price Amgen Inc. is trading at, 173.97 (1.13% today), Amgen Inc. has a dividend yield of 2.33%, and this is covered by a payout ratio of *TBA. Earnings per share (EPS) is 9.45, and this is looking to grow in the next year to 9.30% after growing 35.20% this past year. EPS growth quarter over quarter is 13.10%, and 5.90% for sales growth quarter over quarter.
The number of shares outstanding is 751, and the number of shares float is 750.35. The senior management bring insider ownership to 0.20%, and institutional ownership is at 81.70%. The float short is 1.04%, with the short ratio at a value of 2.74. Management has seen a return on assets of *TBA, and also a return on investment of 12.50%.
The ability for Amgen Inc., to deal with debt, means it current ratio is 4, and quick ratio is 3.7. Long term debt/equity is *TBA and total debt/equity is *TBA. In terms of margins, Amgen Inc. has a gross margin of 81.00%, with its operating margin at 41.30%, and Amgen Inc. has a profit margin of *TBA.
The 52 week high is -2.07%, with 36.23% being its 52 week low. The 20 day simple moving average is 10.75% and the 200 day simple moving average is 13.10%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.